Effects of Nasal Calcitonin on Bone Microarchitecture in Postmenopausal Women
Author Information
Author(s): Richert Laura, Uebelhart Brigitte, Engelhardt Marc, Azria Moise, Rizzoli René
Primary Institution: University Hospitals of Geneva
Hypothesis
We hypothesize that compared to placebo, calcitonin impacts microstructural parameters, with a possible difference between weight bearing and non-weight bearing bones.
Conclusion
The study aims to provide insights into how nasal calcitonin affects bone microarchitecture in postmenopausal women.
Supporting Evidence
- Nasal calcitonin has been shown to prevent postmenopausal bone loss.
- Calcitonin can increase lumbar spine BMD and reduce vertebral fracture risk.
- High-resolution p-QCT allows for efficient evaluation of bone microarchitecture.
Takeaway
This study is looking at how a nasal spray of calcitonin can help improve bone health in older women.
Methodology
A randomized, placebo-controlled, double-blind trial over two years assessing the effects of nasal calcitonin on bone microarchitecture using high-resolution p-QCT.
Limitations
Women with osteoporosis are excluded from the study for ethical reasons.
Participant Demographics
Postmenopausal women aged 45 to 70 years with a BMD T-Score between 0.0 and -2.49.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website